TARRYTOWN, N.Y., April 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
Baird’s 2013 Growth Stock Conference on Wednesday, May 8, 2013. The presentation is scheduled for 10:45 a.m. Eastern Time (9:45 a.m. Central Time).
Credit Suisse 2013 Antibody Day on Friday, May 10, 2013. The presentation is scheduled for 7:45 a.m. Eastern Time.
- Bank of America Merrill Lynch 2013 Healthcare Conference on Tuesday, May 14, 2013. The presentation is scheduled for 6:40 p.m. Eastern Time (3:40 p.m. Pacific Time).
The presentations may be accessed through the Company’s web site, www.regeneron.com, on the ‘Events and Presentations’ page. An archived version of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
Contact Information: | |
Manisha Narasimhan, Ph.D. | Peter Dworkin |
Investor Relations | Corporate Communications |
914.847.5126 | 914.847.7640 |
SOURCE Regeneron Pharmaceuticals, Inc.
